SCHEMBL2215429

SCHEMBL2215429

COC(=O)c1ccc(/C=N/Cc2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.60
HTT P42858 1/20 0.60
KMT2A Q03164 1/20 0.60
CA1 P00915 3/20 0.58
CA2 P00918 3/20 0.58
TSHR P16473 1/20 0.51
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
MAPT P10636 2/20 0.50
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50
GRIN3A Q8TCU5 1/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215434 1.00 L3MBTL1 (0.60) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL2581136 0.92 NPC1 (0.58) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL2581135 0.92 NPC1 (0.58) L3MBTL1HTTKMT2ACA1CA2
Hydrochloric Acid SCHEMBL5676903 0.85 LOXL2 (0.65) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL21715570 0.81 POLB (0.54) L3MBTL1KMT2ARAB9ANPC1MAPT
SCHEMBL19439618 0.81 ALDH1A1 (0.59) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL17273824 0.80 KMT2A (0.71) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL8495136 0.79 G6PC1 (0.64) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL8495137 0.79 G6PC1 (0.64) L3MBTL1HTTKMT2ACA1CA2
SCHEMBL27627334 0.78 NPC1 (0.56) L3MBTL1HTTKMT2ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981874-B2 Phosphorus derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2011-07-19 US disclosed
US-20090270351-A1 PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME CORP. 2009-10-29 US disclosed
EP-2049124-A2 PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS Merck & Co., Inc. (US) 2009-04-22 EP disclosed
WO-2008010985-A2 PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270351-A1 PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC5, PPM1A, PTEN L3MBTL1 2929/4885HTT 988/4885KMT2A 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.